Investors Capital Advisory Services’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Investors Capital Advisory Services’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,041	Closed	-$75K	–	771
2015 Q1	$75K	Sell	8,041 -429	-5%	-$4.13K	0.01%	687
2014 Q4	$82K	Sell	8,470 -571	-6%	-$5.75K	0.02%	660
2014 Q3	$86K	Hold	9,041	–	–	0.02%	646
2014 Q2	$118K	Sell	9,041 -214	-2%	-$2.7K	0.02%	632
2014 Q1	$123K	Buy	9,255 +2,507	+37%	+$33K	0.03%	589
2013 Q4	$65K	Buy	6,748 +1,457	+28%	+$13.7K	0.02%	600
2013 Q3	$51K	Buy	5,291 +5	+0.1%	+$50	0.01%	569
2013 Q2	$47K	Buy	+5,286	New	+$55.4K	0.01%	526

Other funds holding CDMO

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return

Investors Capital Advisory Services's CDMO Position: Q2 2015 in Review

Investors Capital Advisory Services sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2015, closing a stake of 8,041 shares — an estimated $75K sold.

Investors Capital Advisory Services first reported a position in CDMO in Q2 2013 and held it in 8 quarters. The position peaked at $123K in Q1 2014. 90 funds tracked by Wall St. Rank hold CDMO as of Q2 2015.

Investors Capital Advisory Services reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
Investors Capital Advisory Services sold 8,041 Avid Bioservices, Inc. Common Stock shares in Q2 2015, an estimated $75K.
Investors Capital Advisory Services first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
Investors Capital Advisory Services's Avid Bioservices, Inc. Common Stock position peaked at $123K in Q1 2014.
90 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2015.

Based on Investors Capital Advisory Services's 13F filing for Q2 2015, filed 3 Aug 2015.